EASCRA THERAPEUTICS

Delivery systems for medicinal therapeutics, namely, Janus Base nanotubes; delivery systems for medicinal therapeutics, namely, mRNA nanotubes; medicinal therapeutics delivery systems for the treatment of diseases, namely, Janus Base nanotubes; medicinal therapeutics delivery systems for the treatment of cancers and neurological conditions, namely, Janus Base nanotubes; medicinal therapeutics delivery systems for the treatment of neurological conditions, namely, neurodegenerative diseases, namely, Janus Base nanotubes